EUVIMEDEUVIMED entdecken
Fallbericht

Acute Portal and Superior Mesenteric Vein Thrombosis with Topical Testosterone Therapy: An Adverse Drug Event Case Report

Megan R Adams, Kyle D Pijut iD, Kelsey C Uttal-Veroff, George A Davis

Journal of Pharmacy Practice · 2023-08 · 36 (4) · 988-992

DOI: 10.1177/08971900211073286 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Pharmacy Practice, online erschienen am 07.01.2022. Verfasst von Megan R Adams und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Kentucky College of Pharmacy, Lexington, KY, USA. Hauptthemen laut MEDLINE: Venous Thromboembolism, Venous Thrombosis, Thrombosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This is a case report of a 55-year-old Caucasian male prescribed topical testosterone therapy for 12 months prior to admission, when he was diagnosed with acute thrombosis in the portal vein (PVT) and superior mesenteric vein (SMV). The patient had a negative thrombophilia workup, including Factor V Leiden, Prothrombin G20210A, and JAK2 V617F mutations. There were no other pertinent laboratory markers that raised concern for the cause of thrombus. No strong familial history of venous thromboembolism (VTE) was reported during the patient’s initial workup. With this in mind, the patient’s use of topical testosterone therapy was considered the most likely risk factor for the PVT and SMV thrombus. During hospitalization, the patient was initiated on therapeutic anticoagulation with a heparin drip and discharged to home on apixaban for 3 months with extended therapy to be determined by outpatient hematologist. With no other identified VTE risk factors, probability that this patient’s VTE was attributed to testosterone was evaluated using the Naranjo scale with a calculated score of 6, which classifies the adverse reaction as “likely.” Clinicians should be aware of the possibility that topical testosterone therapy may be a risk factor for venous thrombosis in unusual sites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismVenous ThrombosisThrombosisHumansMaleMiddle AgedMesenteric VeinsTestosterone

Stichwörter der Autor:innen

portal vein thrombosissuperior mesenteric veintestosteronethromboembolismthrombosis

Substanzen

Testosterone

Autor:innen und Institutionen

  • University of Kentucky College of Pharmacy, Lexington, KY, USA.
  • University of Kentucky Healthcare Albert B. Chandler Hospital, Lexington, KY, USA.

ORCID-Profile: Kyle D Pijut

Zitieren

APA

Adams, M. R., Pijut, K. D., Uttal-Veroff, K. C., & Davis, G. A. (2023). Acute Portal and Superior Mesenteric Vein Thrombosis with Topical Testosterone Therapy: An Adverse Drug Event Case Report. Journal of Pharmacy Practice, 36(4), 988-992. https://doi.org/10.1177/08971900211073286

Vancouver

Adams MR, Pijut KD, Uttal-Veroff KC, Davis GA. Acute Portal and Superior Mesenteric Vein Thrombosis with Topical Testosterone Therapy: An Adverse Drug Event Case Report. Journal of Pharmacy Practice. 2023;36(4):988-992. doi:10.1177/08971900211073286

BibTeX
@article{Adams2023,
  author = {Adams, Megan R and Pijut, Kyle D and Uttal-Veroff, Kelsey C and Davis, George A},
  title = {Acute Portal and Superior Mesenteric Vein Thrombosis with Topical Testosterone Therapy: An Adverse Drug Event Case Report},
  journal = {Journal of Pharmacy Practice},
  year = {2023},
  volume = {36},
  number = {4},
  pages = {988--992},
  doi = {10.1177/08971900211073286}
}
Kostenlos starten →